- Home
- Equities - Stocks - Shares
- Company Press Releases
- Encouraging Preliminary Results of The Phase II Clinical Study of Inecalcitol In Chronic Myeloid Leukemia
09 Feb 2017 18:00 CET
ATON
HYBRIGENICS
Euronext
ATON
FR0004153930
ALTAO
Euronext Growth